Experimental, metabolic, and clinical aspects of the use of metaprebiotics
Open Access
- 1 July 2026
- journal article
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 8,p. 170-181
Abstract
Disorders of the intestinal microbiocenosis are considered to be one of the pathogenetic mechanisms of the occurrence and progression of not only diseases of the gastrointestinal tract, but also other diseases, exactly oncological, allergic, autoimmune, dermatological, neurological, neuropsychiatric and metabolic disorders. Modern methods, in particular, genomic sequencing, have revealed a large number of previously unknown species and genera of the intestinal microbiota, the role of which is only beginning to be clarified. In this regard, the metabolic activity of the microbiota is currently becoming increasingly important. The main metabolites of a healthy microbiota are short-chain fatty acids, which have metabolic and regulatory effects on both the host and the microbiota itself. There are various tools for correcting the microbiota, such as probiotics, prebiotics, and metabiotics. The combination of probiotics and prebiotics in symbiotics aims to improve their properties. This review focuses on the combination of the metabiotics calcium lactate and the prebiotics inulin and oligofructose. This combination can be considered as a separate subclass of agents metaprebiotic with a synergistic effect on the microbiota. The article examines the experimental effect of calcium lactate on colonization resistance, the protective effect on the normal microbiota, and the rate of restoration of the host microbiota in antibiotic-induced dysbiosis in animals. The article also evaluates the effect of a metaprebiotic on the metabolic function of the microbiota in patients with functional bowel disorders. The clinical efficacy of metaprebiotic use on symptoms and stool frequency has been demonstrated in patients with functional bowel disorders of different ages, as well as in dermatological diseases.Keywords
This publication has 31 references indexed in Scilit:
- Microbiota in health and diseasesSignal Transduction and Targeted Therapy, 2022
- The microbiota–gut–brain axis: pathways to better brain health. Perspectives on what we know, what we need to investigate and how to put knowledge into practiceCellular and Molecular Life Sciences, 2022
- GPR31-dependent dendrite protrusion of intestinal CX3CR1+ cells by bacterial metabolitesNature, 2019
- Culturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulationNature, 2016
- The Plant Microbiome at WorkMolecular Plant-Microbe Interactions®, 2015
- The human microbiome: at the interface of health and diseaseNature Reviews Genetics, 2012
- The Human Microbiome ProjectNature, 2007
- Psychometric Validation of a Constipation Symptom Assessment QuestionnaireScandinavian Journal of Gastroenterology, 1999
- Fructans of chicory: intestinal transport and fermentation of different chain lengths and relation to fructose and sorbitol malabsorptionThe American Journal of Clinical Nutrition, 1998
- A constipation scoring system to simplify evaluation and management of constipated patientsDiseases of the Colon & Rectum, 1996